Physician profile
Yakov Isakov
NPI 1205096310
$8,508.86
in general payments reported to CMS, 2019-2025
30 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,632 · 2020: $1,827 · 2021: $536 · 2022: $1,150 · 2023: $1,025 · 2024: $779 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,365.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,617.65 | 2021-2025 | |
| Biogen, INC. | $1,003.57 | 2019-2024 | Vumerity |
| Teva Pharmaceuticals USA, INC. | $669.18 | 2019-2020 | |
| Allergan, INC. | $504.99 | 2019-2020 | |
| Genzyme Corporation | $500.87 | 2019-2020 | |
| Lilly USA, LLC | $433.21 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $384.96 | 2020-2021 | |
| Amgen INC. | $332.40 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $276.79 | 2019-2020 | |
| Horizon Therapeutics Plc | $250.77 | 2022 | |
| Akcea Therapeutics, INC. | $250.25 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $234.75 | 2020 | |
| Acadia Pharmaceuticals INC | $145.58 | 2020 | |
| Emd Serono, INC. | $131.45 | 2020 | |
| Lundbeck LLC | $123.37 | 2025 | Vyepti |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $89.69 | 2023 | |
| Ucb, INC. | $89.58 | 2019 | |
| Celgene Corporation | $64.16 | 2025 | Zeposia |
| Sunovion Pharmaceuticals INC. | $63.30 | 2019 | |
| Neurocrine Biosciences, INC. | $57.85 | 2019-2020 | |
| Livanova USA, INC. | $52.48 | 2019 | |
| Avanir Pharmaceuticals, INC. | $43.82 | 2019 | |
| Bausch Health US, LLC | $39.00 | 2019 | |
| Medtronic, INC. | $27.23 | 2024 | Percept PC Brainsense |
| Alexion Pharmaceuticals, INC. | $25.99 | 2020 | |
| Grifols USA, LLC | $24.89 | 2019 | |
| Mdd US Operations, LLC | $22.07 | 2019 | |
| Csl Behring | $18.96 | 2020 | |
| Strongbridge US INC. | $17.09 | 2019 | |
| Boston Scientific Corporation | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yakov Isakov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.